DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151412

Effect of ticlopidine on acute and subacute models of inflammation in male wistar rats: an experimental study

medip editor1

Abstract


Background: Atherosclerosis and its complications remains the major cause of death and premature disability. Atherogenesis involves elements of inflammation, a process that now provides a unifying theme in the pathogenesis of the disease. Anti-platelet drugs are currently used in the treatment of atherosclerosis and its complications. Our study evaluated the influence of ticlopidine on acute and sub-acute models of inflammation in male Wistar rats.

Methods: Male wistar rats (150-200g) were divided into three groups i.e. control, Aspirin and ticlopidine (n=6 animals in each group). The effect of ticlopidine, administered orally, on inflammation was studied using acute (carrageenan induced rat paw edema) and sub-acute (cotton pellet granuloma and histopathological examination of grass piths) models. Experiment was conducted according to the Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA) guidelines. Analysis was done using one way ANOVA followed by Post Hoc Test of Dunnets. P<0.05 was considered as statistically significant.

Results: Ticlopidine showed significant inhibition of rat paw oedema in acute model (P<0.01) and granuloma dry weight, in subacute model of inflammation when compared to control (P<0.01). Histopathological examination of grass pith revealed markedly reduced fibroblasts, granulation tissue, fibrous tissue and collagen in ticlopidine group when compared to control.

Conclusions: Ticlopidine exhibited a significant anti-inflammatory activity in acute and sub-acute models of inflammation.

 


Keywords


Ticlopidine, Aspirin, Carrageenan, Inflammation

Full Text:

PDF

References


Park K. Park`s textbook of preventive and social medicine. 21st ed. Jabalpur (M. P.): M/s Banarsidas Bhanot Publishers, 2011.

Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison’s principles of internal medicine. 18th edition. New York: McGraw Hill Publishers, 2012.

Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis. Transition from theory to practice. Circ J. 2010;74:213-20.

Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Lüscher TF. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med. 2007;12:113-22.

Hu CJ, Lee YL, Shih NY, Yang YY, Charoenfuprasert S, Dai YS. Reduction of Monocyte Chemoattractant Protein-1 and Interleukin-8 Levels by Ticlopidine in TNF-α Stimulated Human Umbilical Vein Endothelial Cells. Journal of Biomedicine and Biotechnology. 2009:917837.

Jawien J, Csanyi G, Gajda M, Mateuszuk, Lomnicka M. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice. Er J of Pharmacol. 2007;556,129-35.

Laurence DR, Bacharach AL. Evaluation of Drug Activities: Pharmacometrics. Vol. 2. New York and London: Academic Press Inc, 1964.

Sweetman SC. Martindale The Complete Drug Reference. 36th Edition. London: Pharmaceutical Press; 2009.

Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hindpaw of the rat as an assay for antiiaflammatory drugs. Proc Soc exp Biol Med. 1962;111:544-7.

Gupta SK. Drug screening methods. 2nd edition. New Delhi, Jayapee brothers medical publishers (P) Ltd. 2009:488-9.

Turner RA. Screening Methods in Pharmacology. New York and London:Academic Press Inc; 1965.

Patil PA, Kulkarni DR. Effect of anti proliferative agents on healing of dead space wounds in rats. Ind J Med Res. 1984;79:445-7.

Molero L, Lopez-Farre A, Mateos-Caceres PJ, Fernandez- Sanchez R, Luisa Maestro M, Silva J, et al. Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery. Br J Pharmacology. 2005;146:419-24.

Klinkhardt, U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet–leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther. 2003;73:232-41.

Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115-26.

Angadi NB, Hiremath SV, Suranagi VV, Torgal SS. Evaluation of clopidogrel on acute and sub-acute models of inflammation in male Wistar rats. Int J Basic Clin Pharmacol. 2015;4(2):358-62.

Angadi NB, Hiremath SV, Suranagi VV. Evaluation of dipyridamole on acute and subacute models of inflammation in male wistar rats: an experimental study. IJMRHS. 2015;4(3):540-5.

Sharis PJ, Cannon CP, and Loscalzo J. The Antiplatelet Effects of ticlopidine and clopidogrel. Ann Intern Med. 1998;129(5):394-405.